Related references
Note: Only part of the references are listed.Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
Elodie von Dach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical considerations for oral beta-lactams as step-down therapy for Enterobacteriaceae bloodstream infections
Bryan T. Mogle et al.
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia
Pranita D. Tamma et al.
JAMA INTERNAL MEDICINE (2019)
Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs β-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
Chitra Punjabi et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
Dafna Yahav et al.
CLINICAL INFECTIOUS DISEASES (2019)
Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus β-lactams
Nicholas J. Mercuro et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Adverse events of fluoroquinolones vs. other antimicrobials prescribed in primary care: A systematic review and meta-analysis of randomized controlled trials
M. Tandan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Antimicrobial Agents and Catheter Complications in Outpatient Parenteral Antimicrobial Therapy
Sara C. Keller et al.
PHARMACOTHERAPY (2018)
Comparing the Outcomes of Adults With Enterobacteriaceae Bacteremia Receiving Short-Course Versus Prolonged-Course Antibiotic Therapy in a Multicenter, Propensity Score-Matched Cohort
Darunee Chotiprasitsakul et al.
CLINICAL INFECTIOUS DISEASES (2018)
Rates of and Risk Factors for Adverse Drug Events in Outpatient Parenteral Antimicrobial Therapy
Sara C. Keller et al.
CLINICAL INFECTIOUS DISEASES (2018)
Intravenous-only or Intravenous Transitioned to Oral Antimicrobials for Enterobacteriaceae-Associated Bacteremic Urinary Tract Infection
Krista L. Rieger et al.
PHARMACOTHERAPY (2017)
Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections
Leila F. Kutob et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System
M. E. A. de Kraker et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Incidence of bloodstream infection: a review of population-based studies
K. B. Laupland
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Considerations when prescribing trimethoprim-sulfamethoxazole
Joanne M. -W. Ho et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Budget Impact Analysis of Conversion from Intravenous to Oral Medication When Clinically Eligible for Oral Intake
Brandyn D. Lau et al.
CLINICAL THERAPEUTICS (2011)
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
Leonard A. Mermel et al.
CLINICAL INFECTIOUS DISEASES (2009)
Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis
DA Talan et al.
JOURNAL OF UROLOGY (2004)
Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women - A randomized trial
DA Talan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)